TREM2 and cancer: Collectively, although there are many factors affecting TAM transcriptional signature (i.e., tissue, disease stage, treatment, methodology), TREM2 clearly emerges as a core gene of immunosuppressive TAMs across numerous cancer types (Figure 2).